Disavow.ai vs Oleno

Every website picks up backlinks it didn't ask for — spam networks, link farms, scraper sites. When they cause a Google penalty or tank your rankings, you need to act fast. Disavow.ai scans your backlink profile, classifies every linking domain as clean, suspicious, or toxic using a 4-layer Smart Risk Engine, and generates the exact file Google needs to ignore the bad ones. Toxic domains are grouped into plain-English categories — Spam & Link Farms, Private Blog Networks, Known Spam Patterns, Risky Extensions, and Near-Zero Authority — each showing exactly why it was flagged. No SEO jargon, no black-box scores. Free tier lets you scan and see 15 backlinks. Pro at $39/mo gives you unlimited backlinks, full export, and weekly auto-scans. That's 70% less than Semrush for the same core functionality.

Oleno represents a transformative leap in the realm of content creation, designed to cater specifically to the intricate needs of B2B marketing teams. It transcends the limitations of conventional article generators, functioning as a holistic, autonomous content engine. With the primary aim of addressing the substantial execution gap that many teams face in their content strategies, Oleno is ideal for organizations focused on sustainable organic growth. Unlike traditional tools that merely generate text, Oleno operates within an integrated system attuned to the modern discovery landscape. This landscape demands not only high search engine rankings but also citations from advanced language models like ChatGPT. Oleno intelligently extracts relevant topics from your sitemap and grounds each piece of content in your unique knowledge base, ensuring maximum discoverability. By seamlessly integrating your brand voice and sales narrative, conducting over eighty automated quality assurance checks, and enabling direct publication to your CMS, Oleno replaces fragmented content operations with a coherent solution. This empowers teams to effectively close the 90% gap in their content backlog, enhancing visibility across vital discovery platforms.